Inflammatory  ||| S:0 E:13 ||| JJ
events  ||| S:13 E:20 ||| NNS
at  ||| S:20 E:23 ||| IN
blood-brain  ||| S:23 E:35 ||| JJ
barrier  ||| S:35 E:43 ||| NN
in  ||| S:43 E:46 ||| IN
neuroinflammatory  ||| S:46 E:64 ||| NN
and  ||| S:64 E:68 ||| CC
neurodegenerative  ||| S:68 E:86 ||| JJ
disorders ||| S:86 E:95 ||| NNS
:  ||| S:95 E:97 ||| :
implications  ||| S:97 E:110 ||| NNS
for  ||| S:110 E:114 ||| IN
clinical  ||| S:114 E:123 ||| JJ
disease  ||| S:123 E:131 ||| NN
Proper  ||| S:131 E:138 ||| JJ
function  ||| S:138 E:147 ||| NN
of  ||| S:147 E:150 ||| IN
the  ||| S:150 E:154 ||| DT
neurovasculature  ||| S:154 E:171 ||| NN
is  ||| S:171 E:174 ||| VBZ
required  ||| S:174 E:183 ||| VBN
for  ||| S:183 E:187 ||| IN
optimal  ||| S:187 E:195 ||| JJ
brain  ||| S:195 E:201 ||| NN
function  ||| S:201 E:210 ||| NN
and  ||| S:210 E:214 ||| CC
preventing  ||| S:214 E:225 ||| VBG
neuroinflammation  ||| S:225 E:243 ||| NNS
and  ||| S:243 E:247 ||| CC
neurodegeneration ||| S:247 E:264 ||| NN
.  ||| S:264 E:266 ||| .
Within  ||| S:266 E:273 ||| IN
this  ||| S:273 E:278 ||| DT
review ||| S:278 E:284 ||| NN
,  ||| S:284 E:286 ||| ,
we  ||| S:286 E:289 ||| PRP
discuss  ||| S:289 E:297 ||| VB
alterations  ||| S:297 E:309 ||| VBN
of  ||| S:309 E:312 ||| IN
the  ||| S:312 E:316 ||| DT
function  ||| S:316 E:325 ||| NN
of  ||| S:325 E:328 ||| IN
the  ||| S:328 E:332 ||| DT
blood-brain  ||| S:332 E:344 ||| JJ
barrier  ||| S:344 E:352 ||| NN
in  ||| S:352 E:355 ||| IN
neurologic  ||| S:355 E:366 ||| JJ
disorders  ||| S:366 E:376 ||| NNS
such  ||| S:376 E:381 ||| JJ
as  ||| S:381 E:384 ||| IN
multiple  ||| S:384 E:393 ||| JJ
sclerosis ||| S:393 E:402 ||| NN
,  ||| S:402 E:404 ||| ,
epilepsy ||| S:404 E:412 ||| NN
,  ||| S:412 E:414 ||| ,
and  ||| S:414 E:418 ||| CC
Alzheimer ||| S:418 E:427 ||| NNP
's  ||| S:427 E:430 ||| POS
disease  ||| S:430 E:438 ||| NN
and  ||| S:438 E:442 ||| CC
address  ||| S:442 E:450 ||| VB
potential  ||| S:450 E:460 ||| JJ
underlying  ||| S:460 E:471 ||| JJ
mechanisms ||| S:471 E:481 ||| NNS
.  ||| S:481 E:483 ||| .
